Website được thiết kế tối ưu cho thành viên chính thức. Hãy Đăng nhập hoặc Đăng ký để truy cập đầy đủ nội dung và chức năng. Nội dung bạn cần không thấy trên website, có thể do bạn chưa đăng nhập. Nếu là thành viên của website, bạn cũng có thể yêu cầu trong nhóm Zalo "NCKH Members" các nội dung bạn quan tâm.

Tình hình sử dụng máu, chế phẩm máu tại Viện Huyết học Truyền máu Trung ương năm 2010 - 2011

nckh
Thông tin nghiên cứu
Loại tài liệu
Bài báo trên tạp chí khoa học (Journal Article)
Tiêu đề
Tình hình sử dụng máu, chế phẩm máu tại Viện Huyết học Truyền máu Trung ương năm 2010 - 2011
Tác giả
Nguyễn ích Việt; Bùi Thị Mai An; Nguyễn Quang Tùng; Nguyễn Anh Trí
Năm xuất bản
2012
Số tạp chí
SDB
Trang bắt đầu
479-484
ISSN
1859-1868
Abstract

Blood and blood component are valuable and nowaday there is not any medicines replates it. Blood transfusion is a effective treatment therapy. Initiactive in seting up plan of blood collection, blood component produce to supply sufficiently and timely is necessary. Objectives: "Study on situation of using blood, blood component in clinical department in NIHBT from 2010 to 2011". Materials: Blood units, blood component units were distributed to patients who were treated in clinical department, NIHBT by Blood group serology department from January 2010 to December 2011. Methods: retrospective study. Results: Total of blood and blood component units which were used in NIHBT from 2010 to 2011 were 159,440 units. Total of blood and blood component units which were used in NIHBT in 2011 increased 1.37 times than 2010. Using of blood and blood component units was the highest on March. Using of blood and blood component units in the quarters in 2011 was much more than the same quarter in 2010. Situation of using blood component: packed red cell (41.9 percent), platelet (27.2 percent), fresh frozen plasma (10.4 percent), frozen plasma (8.4 percent), VIII factor cryoprecipitate (7.2 percent), platelet apheresis (4.9 percent). Using of blood and blood component units was the highest in patients with Leukemia group, and the lowest in patients with bone marrow failure and myelofibrosis group. Conclusions: Need of using blood, blood component increased according to time. Blood and blood component units which were used in NIHBT in 2011 increased 1.37 times than 2010. Using of blood and blood component units was the highest on March. Using of blood and blood component units in the quarters in 2011 was much more than the same quarter in 2010. Using of blood and blood component units was the highest in patients with Leukemia group (35.4 percent).